Pharmaceuticals news continually updated from thousands of sources around the net.
2 hrs ago | AmericanBankingNews.com
Cardinal Health CEO Michael C. Kaufmann sold 6,833 shares of the company's stock in a transaction dated Monday, August 18th.
6 hrs ago | Seeking Alpha
The company's adjustments to financial guidance issued as part of the no-inversion announcement confirmed that the tax inversion enthusiasm was masking weakness in Walgreen's business.
10 hrs ago | AmericanBankingNews.com
's stock had its "neutral" rating reissued by Credit Suisse in a research note issued on Thursday.
15 hrs ago | The Motley Fool
I say haystack because a lot of companies have paid a dividend, be it a regular dividend or special one, over the trailing 12 months -- and not all of those dividends are exactly high quality.
19 hrs ago | WKXW-FM Trenton
He said while New Jersey remains a central location for pharmaceutical companies, some have departed because of the state's high taxes.
Today, Analysts Review released its research reports regarding Covidien PLC , Mylan, Inc. , Baxter International Inc. , Achillion Pharmaceuticals, Inc. and Perrigo Company PLC .
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Achillion Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No.
Phase I study to evaluate OPDIVO , Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, with Celgene's ABRAXANE A for multiple cancers NEW YORK & SUMMIT, N.J.-- -- Bristol-Myers Squibb Company and Celgene Corporation announced today the establishment of a clinical trial collaboration to evaluate the safety, tolerability and ... (more)
Achillion Pharmaceuticals major shareholder Ra Capital Management, Llc sold 4,235,000 shares of the company's stock in a transaction that occurred on Monday, August 18th.
Market highs have been a frequent occurrence so far in 2014, and the healthcare sector has been no stranger to the stock surge.
Both Mr. Abravanel and Dr. Ariely-Portnoy have substantial expertise, experience and knowledge relevant to the Company's mission and anticipated needs.
Mylan Inc. announced that its business Mylan Institutional has launched Dexmedetomidine Hydrochloride Injection, 100 mcg /mL, packaged in 200 mcg /2 mL Single-dose Vials, which is therapeutically equivalent to Hospira's Precedex .
Bob Turner: At Turner, we're encouraged by what we see in the market in general.
Unimed Pharmaceuticals LLC et al. v. Perrigo Co. et al. 1:14-cv-01004; filed July 31, 2014 in the District Court of Delaware Unimed Pharmaceuticals LLC et al. v.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Impax Laboratories Inc. securities during the period between May 20, 2013 and July 28, 2014, inclusive .
Updated: Thu Aug 21, 2014 09:06 pm
Copyright © 2014 Topix LLC